SGLT-2 Inhibitors Tied to Lower Risk for Autoimmune Rheumatic Diseases in Adults With T2D

SGLT-2 Inhibitors Tied to Lower Risk for Autoimmune Rheumatic Diseases in Adults With T2D Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmu…